Jaguar Health (JAGX) Liabilities and Shareholders Equity (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $37.4 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 27.26% year-over-year to $37.4 million in Q1 2026; TTM through Mar 2026 was $139.2 million, a 38.09% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 92.51% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $37.4 million, up from $4.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for JAGX reached as high as $61.5 million in Q2 2024 and fell as low as $4.0 million in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $48.6 million across 5 years, with a median of $51.3 million in 2022.
• Across the five-year window, Liabilities and Shareholders Equity climbed 28.84% in 2024 and sank 92.51% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $47.5 million in 2022, then rose by 6.98% to $50.8 million in 2023, then climbed by 5.24% to $53.4 million in 2024, then sank by 92.51% to $4.0 million in 2025, then surged by 835.85% to $37.4 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $37.4 million in Q1 2026, $4.0 million in Q4 2025, and $49.5 million in Q3 2025.